Yi Tat Tong

Also affiliated with Renji Hospital, Shanghai Cancer Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy”.

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy

Cancers(2023)10.3390/cancers15092608

N/A

0.345DataRank · unranked

9 citations

Zongshan Lai, Matthew H. G. Katz, Laura R. Prakash, Hua Wang, Deyali Chatterjee +11 more

The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy

Cancers(2024)10.3390/cancers16193312

N/A

0DataRank · unranked

1 citations

Matthew H. G. Katz, Laura R. Prakash, Dongguang Wei, Yi Tat Tong, Zongshan Lai +11 more